Clinical Trial Update: Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial results of TA-650 in pediatric ulcerative colitis have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• TA-650

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Pediatric Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2019-10-21